Endocrine Peptide Test Market Report 2026
Endocrine Peptide Test Market Global Report 2026 Market Report Infographic Image
Item added to cart!

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Endocrine Peptide Test Market Report 2026

Global Outlook – By Test-Type (Dehydroepiandrosterone Sulphate, Progesterone, Luteinizing Hormone, Thyroid Prolactin, Oestradiol, Human Chorionic Gonadotropin, Thyroid-Stimulating Hormone, Other Test-Types), By Technology (Mass Spectroscopy, Immunoassay, Chromatography, Nucleic Acid Based, Other Technologies), By End-User (Clinics, Healthcare Centers, Hospitals, Commercial Laboratories) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Endocrine Peptide Test Market Overview

• Endocrine Peptide Test market size has reached to $9.95 billion in 2025

• Expected to grow to $14.88 billion in 2030 at a compound annual growth rate (CAGR) of 8.1%

• Growth Driver: Impact of Diabetes Prevalence on Endocrine Peptide Test Market Growth

• Market Trend: Advancements in Immunoassay Testing Systems for Endocrine Peptide Testing

North America was the largest region in 2025.

What Is Covered Under Endocrine Peptide Test Market?

Endocrine peptide test refers to a diagnostic test used to measure the levels of specific peptides (small proteins) in the blood or urine that are related to the functioning of the endocrine system. The primary aim of the endocrine peptide test is to diagnose and monitor endocrine disorders by measuring specific peptide hormones in the blood.

The main types of tests in endocrine peptide test market are dehydroepiandrosterone sulphate, progesterone, luteinizing hormone, thyroid prolactin, oestradiol, human chorionic gonadotropin, thyroid-stimulating hormone, and others. The dehydroepiandrosterone sulfate (DHEAS) test is a blood test that measures the levels of DHEAS in the body. The various technologies include mass spectroscopy, immunoassay, chromatography, nucleic acid based, and others. The end users are clinics, healthcare centers, hospitals, and commercial laboratories.

Endocrine Peptide Test Market Global Report 2026 Market Report bar graph

What Is The Endocrine Peptide Test Market Size and Share 2026?

The endocrine peptide test market size has grown strongly in recent years. It will grow from $9.95 billion in 2025 to $10.88 billion in 2026 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to growth in endocrine disorders, expansion of diagnostic laboratories, hormone imbalance awareness, advancements in immunoassay techniques, clinical endocrinology expansion.

What Is The Endocrine Peptide Test Market Growth Forecast?

The endocrine peptide test market size is expected to see strong growth in the next few years. It will grow to $14.88 billion in 2030 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to precision medicine adoption, advanced biomarker research, automation in diagnostic labs, personalized endocrine care, demand for early diagnosis. Major trends in the forecast period include rising demand for hormone disorder diagnostics, increased use of peptide biomarkers, growth in early endocrine disease detection, expansion of laboratory-based specialized testing, focus on accurate hormonal monitoring.

Customer representative image Book your 30 minutes free consultation with our research experts

Global Endocrine Peptide Test Market Segmentation

1) By Test-Type: Dehydroepiandrosterone Sulphate, Progesterone, Luteinizing Hormone, Thyroid Prolactin, Oestradiol, Human Chorionic Gonadotropin, Thyroid-Stimulating Hormone, Other Test-Types

2) By Technology: Mass Spectroscopy, Immunoassay, Chromatography, Nucleic Acid Based, Other Technologies

3) By End-User: Clinics, Healthcare Centers, Hospitals, Commercial Laboratories

Subsegments:

1) By Dehydroepiandrosterone Sulphate (DHEA-S): Immunoassay Tests, Enzyme-Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA)

2) By Progesterone: Immunoassay Tests, Chemiluminescence Assays, ELISA Tests

3) By Luteinizing Hormone: Immunoassay Tests, Enzyme Immunoassay (EIA), Radioimmunoassay (RIA)

4) By Thyroid Prolactin: Immunoassay Tests, Chemiluminescence Assays, Radioimmunoassay (RIA)

5) By Oestradiol: Immunoassay Tests, Enzyme-Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA)

6) By Human Chorionic Gonadotropin (hCG): Immunoassay Tests, Chemiluminescence Assays, Enzyme Immunoassay (EIA)

7) By Thyroid-Stimulating Hormone (TSH): Immunoassay Tests, Radioimmunoassay (RIA), Enzyme-Linked Immunosorbent Assay (ELISA)

8) By Other Test-Types: Cortisol, Insulin, Growth Hormone (GH), Parathyroid Hormone (PTH)

What Is The Driver Of The Endocrine Peptide Test Market?

The rising prevalence of diabetes is expected to propel the growth of the endocrine peptide test market going forward. Diabetes refers to a group of diseases that result in high blood sugar (glucose) levels. The prevalence of diabetes is increasing due to factors such as unhealthy diets, sedentary lifestyles, genetic predisposition, and an aging population. Endocrine peptide test, including hemoglobin A1c, fasting plasma glucose, and C-peptide tests, is used in diabetes to diagnose the condition, monitor glucose levels, and assess insulin production and sensitivity. For instance, in June 2024, according to the National Health Service (NHS), UK-based government department, the number of individuals under 40 diagnosed with diabetes increased significantly, rising from 173,166 in 2022 to 216,440 in 2023. This sharp growth underscores a concerning trend of rising diabetes prevalence in younger populations. Therefore, the rising prevalence of diabetes is driving the endocrine peptide test industry.

Key Players In The Global Endocrine Peptide Test Market

Major companies operating in the endocrine peptide test market are Siemens AG, F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Merck KGaA, Becton Dickinson and Company, Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., bioMérieux SA, Bio-Rad Laboratories Inc., DiaSorin S.p.A., Sciex, Bio-Techne Corporation, Invitae Corporation, ARUP Laboratories, Genova Diagnostics, Boston Heart Diagnostics Corporation, Immunodiagnostic Systems Ltd., Mayo Clinic Laboratories

Global Endocrine Peptide Test Market Trends and Insights

Major companies operating in the endocrine peptide test market are developing immunoassay testing systems to improve endocrine peptide testing accuracy, sensitivity, and speed. These testing systems use antibodies to detect and measure specific peptides in blood or urine samples, providing healthcare professionals with valuable information about hormone levels and endocrine function. For instance, in July 2023, Siemens Healthineers, a German-based healthcare services company, launched Atellica CI Analyzer, a compact system for immunoassay and clinical chemistry testing, including endocrine peptide assays. The analyzer also features a reproductive endocrinology menu that includes anti-Mullerian hormone (AMH) to determine ovarian reserve and sFlt-1 and PlGF (placental growth factor) to aid in the prognosis of preeclampsia. The Atellica CI Analyzer is designed to deliver quality results quickly and consistently, with up to 1000 tests per hour capacity. It provides workflow efficiency and flexibility to help labs meet evolving testing needs.

Need data on a specific region in this market?

What Are Latest Mergers And Acquisitions In The Endocrine Peptide Test Market?

In March 2025, Laboratory Corporation of America Holdings a US-based healthcare diagnostics company, acquired SYNLAB for an undisclosed amount. With this investment, Labcorp aims to deepen its presence in the European diagnostics market, leveraging SYNLAB’s scale and network to bring its specialty testing capabilities to new markets and explore procurement and clinical-trial synergies. SYNLAB AG is a Germany-based company that provides Endocrine Peptide Tests as part of its extensive range of routine and specialized medical diagnostic services.

Regional Outlook

North America was the largest region in the endocrine peptide test market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Endocrine Peptide Test Market?

The endocrine peptide test market includes revenues earned by entities by providing services such as diagnostic testing, laboratory analysis, research studies, and clinical evaluations. The market value includes the value of related goods sold by the service provider or included within the service offering. The endocrine peptide test market also includes sales of diagnostic kits, reagents, testing instruments, and laboratory equipment. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Endocrine Peptide Test Market Report 2026?

The endocrine peptide test market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the endocrine peptide test industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Endocrine Peptide Test Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $10.88 billion
Revenue Forecast In 2035 $14.88 billion
Growth Rate CAGR of 9.3% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Test-Type, Technology, End-User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Siemens AG, F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Merck KGaA, Becton Dickinson and Company, Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., bioMérieux SA, Bio-Rad Laboratories Inc., DiaSorin S.p.A., Sciex, Bio-Techne Corporation, Invitae Corporation, ARUP Laboratories, Genova Diagnostics, Boston Heart Diagnostics Corporation, Immunodiagnostic Systems Ltd., Mayo Clinic Laboratories
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Endocrine Peptide Test Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Endocrine Peptide Test Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Endocrine Peptide Test Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Endocrine Peptide Test Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Industry 4.0 & Intelligent Manufacturing

4.1.4 Artificial Intelligence & Autonomous Intelligence

4.1.5 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Rising Demand For Hormone Disorder Diagnostics

4.2.2 Increased Use Of Peptide Biomarkers

4.2.3 Growth In Early Endocrine Disease Detection

4.2.4 Expansion Of Laboratory-Based Specialized Testing

4.2.5 Focus On Accurate Hormonal Monitoring

5. Endocrine Peptide Test Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Diagnostic Laboratories

5.3 Clinics

5.4 Healthcare Centers

5.5 Research Institutes

6. Endocrine Peptide Test Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Endocrine Peptide Test Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Endocrine Peptide Test PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Endocrine Peptide Test Market Size, Comparisons And Growth Rate Analysis

7.3. Global Endocrine Peptide Test Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Endocrine Peptide Test Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Endocrine Peptide Test Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Endocrine Peptide Test Market Segmentation

9.1. Global Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Dehydroepiandrosterone Sulphate, Progesterone, Luteinizing Hormone, Thyroid Prolactin, Oestradiol, Human Chorionic Gonadotropin, Thyroid-Stimulating Hormone, Other Test-Types

9.2. Global Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Mass Spectroscopy, Immunoassay, Chromatography, Nucleic Acid Based, Other Technologies

9.3. Global Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Clinics, Healthcare Centers, Hospitals, Commercial Laboratories

9.4. Global Endocrine Peptide Test Market, Sub-Segmentation Of Dehydroepiandrosterone Sulphate, By Test-Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Immunoassay Tests, Enzyme-Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA)

9.5. Global Endocrine Peptide Test Market, Sub-Segmentation Of Progesterone, By Test-Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Immunoassay Tests, Chemiluminescence Assays, ELISA Tests

9.6. Global Endocrine Peptide Test Market, Sub-Segmentation Of Luteinizing Hormone, By Test-Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Immunoassay Tests, Enzyme Immunoassay (EIA), Radioimmunoassay (RIA)

9.7. Global Endocrine Peptide Test Market, Sub-Segmentation Of Thyroid Prolactin, By Test-Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Immunoassay Tests, Chemiluminescence Assays, Radioimmunoassay (RIA)

9.8. Global Endocrine Peptide Test Market, Sub-Segmentation Of Oestradiol, By Test-Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Immunoassay Tests, Enzyme-Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA)

9.9. Global Endocrine Peptide Test Market, Sub-Segmentation Of Human Chorionic Gonadotropin, By Test-Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Immunoassay Tests, Chemiluminescence Assays, Enzyme Immunoassay (EIA)

9.10. Global Endocrine Peptide Test Market, Sub-Segmentation Of Thyroid-Stimulating Hormone, By Test-Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Immunoassay Tests, Radioimmunoassay (RIA), Enzyme-Linked Immunosorbent Assay (ELISA)

9.11. Global Endocrine Peptide Test Market, Sub-Segmentation Of Other Test-Types, By Test-Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Cortisol, Insulin, Growth Hormone (GH), Parathyroid Hormone (PTH)

10. Endocrine Peptide Test Market Regional And Country Analysis

10.1. Global Endocrine Peptide Test Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Endocrine Peptide Test Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Endocrine Peptide Test Market

11.1. Asia-Pacific Endocrine Peptide Test Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Endocrine Peptide Test Market, Segmentation By Test-Type, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Endocrine Peptide Test Market

12.1. China Endocrine Peptide Test Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Endocrine Peptide Test Market, Segmentation By Test-Type, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Endocrine Peptide Test Market

13.1. India Endocrine Peptide Test Market, Segmentation By Test-Type, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Endocrine Peptide Test Market

14.1. Japan Endocrine Peptide Test Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Endocrine Peptide Test Market, Segmentation By Test-Type, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Endocrine Peptide Test Market

15.1. Australia Endocrine Peptide Test Market, Segmentation By Test-Type, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Endocrine Peptide Test Market

16.1. Indonesia Endocrine Peptide Test Market, Segmentation By Test-Type, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Endocrine Peptide Test Market

17.1. South Korea Endocrine Peptide Test Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Endocrine Peptide Test Market, Segmentation By Test-Type, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Endocrine Peptide Test Market

18.1. Taiwan Endocrine Peptide Test Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Endocrine Peptide Test Market, Segmentation By Test-Type, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Endocrine Peptide Test Market

19.1. South East Asia Endocrine Peptide Test Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Endocrine Peptide Test Market, Segmentation By Test-Type, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Endocrine Peptide Test Market

20.1. Western Europe Endocrine Peptide Test Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Endocrine Peptide Test Market, Segmentation By Test-Type, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Endocrine Peptide Test Market

21.1. UK Endocrine Peptide Test Market, Segmentation By Test-Type, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Endocrine Peptide Test Market

22.1. Germany Endocrine Peptide Test Market, Segmentation By Test-Type, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Endocrine Peptide Test Market

23.1. France Endocrine Peptide Test Market, Segmentation By Test-Type, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Endocrine Peptide Test Market

24.1. Italy Endocrine Peptide Test Market, Segmentation By Test-Type, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Endocrine Peptide Test Market

25.1. Spain Endocrine Peptide Test Market, Segmentation By Test-Type, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Endocrine Peptide Test Market

26.1. Eastern Europe Endocrine Peptide Test Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Endocrine Peptide Test Market, Segmentation By Test-Type, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Endocrine Peptide Test Market

27.1. Russia Endocrine Peptide Test Market, Segmentation By Test-Type, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Endocrine Peptide Test Market

28.1. North America Endocrine Peptide Test Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Endocrine Peptide Test Market, Segmentation By Test-Type, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Endocrine Peptide Test Market

29.1. USA Endocrine Peptide Test Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Endocrine Peptide Test Market, Segmentation By Test-Type, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Endocrine Peptide Test Market

30.1. Canada Endocrine Peptide Test Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Endocrine Peptide Test Market, Segmentation By Test-Type, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Endocrine Peptide Test Market

31.1. South America Endocrine Peptide Test Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Endocrine Peptide Test Market, Segmentation By Test-Type, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Endocrine Peptide Test Market

32.1. Brazil Endocrine Peptide Test Market, Segmentation By Test-Type, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Endocrine Peptide Test Market

33.1. Middle East Endocrine Peptide Test Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Endocrine Peptide Test Market, Segmentation By Test-Type, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Endocrine Peptide Test Market

34.1. Africa Endocrine Peptide Test Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Endocrine Peptide Test Market, Segmentation By Test-Type, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Endocrine Peptide Test Market Regulatory and Investment Landscape

36. Endocrine Peptide Test Market Competitive Landscape And Company Profiles

36.1. Endocrine Peptide Test Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Endocrine Peptide Test Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Endocrine Peptide Test Market Company Profiles

36.3.1. Siemens AG Overview, Products and Services, Strategy and Financial Analysis

36.3.2. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

37. Endocrine Peptide Test Market Other Major And Innovative Companies

Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., bioMérieux SA, Bio-Rad Laboratories Inc., DiaSorin S.p.A., Sciex, Bio-Techne Corporation, Invitae Corporation, ARUP Laboratories, Genova Diagnostics, Boston Heart Diagnostics Corporation, Immunodiagnostic Systems Ltd., Mayo Clinic Laboratories

38. Global Endocrine Peptide Test Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Endocrine Peptide Test Market

40. Endocrine Peptide Test Market High Potential Countries, Segments and Strategies

40.1 Endocrine Peptide Test Market In 2030 - Countries Offering Most New Opportunities

40.2 Endocrine Peptide Test Market In 2030 - Segments Offering Most New Opportunities

40.3 Endocrine Peptide Test Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Endocrine Peptide Test Market, Overview Of Key Products - Product Examples
  • Table 2: Global Endocrine Peptide Test Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Endocrine Peptide Test Market, Supply Chain Analysis
  • Table 4: Global Endocrine Peptide Test Market, Major Raw Material Providers
  • Table 5: Global Endocrine Peptide Test Market, Major Resource Providers
  • Table 6: Global Endocrine Peptide Test Market, Major Manufacturers (Suppliers)
  • Table 7: Global Endocrine Peptide Test Market, Major Distributors And Channel Partners
  • Table 8: Global Endocrine Peptide Test Market, Key Technologies & Future Trends
  • Table 9: Global Endocrine Peptide Test Market, Major Trends
  • Table 10: Global Endocrine Peptide Test Market, Major End Users
  • Table 11: Global Endocrine Peptide Test Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Endocrine Peptide Test Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Endocrine Peptide Test Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Endocrine Peptide Test Market - TAM, US$ Billion, 2025
  • Table 15: Global Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Endocrine Peptide Test Market, Sub-Segmentation Of Dehydroepiandrosterone Sulphate, By Test-Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Endocrine Peptide Test Market, Sub-Segmentation Of Progesterone, By Test-Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Endocrine Peptide Test Market, Sub-Segmentation Of Luteinizing Hormone, By Test-Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Endocrine Peptide Test Market, Sub-Segmentation Of Thyroid Prolactin, By Test-Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Endocrine Peptide Test Market, Sub-Segmentation Of Oestradiol, By Test-Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Endocrine Peptide Test Market, Sub-Segmentation Of Human Chorionic Gonadotropin, By Test-Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Global Endocrine Peptide Test Market, Sub-Segmentation Of Thyroid-Stimulating Hormone, By Test-Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Global Endocrine Peptide Test Market, Sub-Segmentation Of Other Test-Types, By Test-Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Global Endocrine Peptide Test Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: Global Endocrine Peptide Test Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: Asia-Pacific, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: Asia-Pacific, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: Asia-Pacific, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: China, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: China, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: China, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: India, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: India, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: India, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Japan, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Japan, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Japan, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Australia, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Australia, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: Australia, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: Indonesia, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Indonesia, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Indonesia, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: South Korea, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: South Korea, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South Korea, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: Taiwan, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Taiwan, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Taiwan, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: South East Asia, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: South East Asia, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: South East Asia, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: Western Europe, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: Western Europe, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Western Europe, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: UK, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: UK, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: UK, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Germany, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Germany, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Germany, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: France, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: France, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: France, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Italy, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Italy, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Italy, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Spain, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Spain, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Spain, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Eastern Europe, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Eastern Europe, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: Eastern Europe, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: Russia, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: Russia, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: Russia, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: North America, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: North America, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: North America, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: USA, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: USA, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: USA, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: Canada, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: Canada, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Canada, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: South America, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: South America, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: South America, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Brazil, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Brazil, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Brazil, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Middle East, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Middle East, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Middle East, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 97: Africa, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 98: Africa, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 99: Africa, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 100: Global Endocrine Peptide Test Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 101: Global Endocrine Peptide Test Market - Company Scoring Matrix
  • Table 102: Siemens AG Financial Performance
  • Table 103: F. Hoffmann-La Roche AG Financial Performance
  • Table 104: Thermo Fisher Scientific Inc. Financial Performance
  • Table 105: Merck KGaA Financial Performance
  • Table 106: Becton Dickinson and Company Financial Performance
  • Table 107: Global Endocrine Peptide Test Market, Competitive Benchmarking (In USD Billions)
  • Table 108: Global Endocrine Peptide Test Market, Competitive Dashboard
  • Table 109: Global Endocrine Peptide Test Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 110: Global, Endocrine Peptide Test Market Size Gain ($ Billion), Segmentation By Test-Type, 2025 – 2030
  • Table 111: Global, Endocrine Peptide Test Market Size Gain ($ Billion), Segmentation By Technology, 2025 – 2030
  • Table 112: Global, Endocrine Peptide Test Market Size Gain ($ Billion), Segmentation By End-User, 2025 – 2030

List Of Figures

    Figure 1: Global Endocrine Peptide Test Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Endocrine Peptide Test Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Endocrine Peptide Test Market, Supply Chain Analysis
  • Figure 4: Global Endocrine Peptide Test Market, Major Raw Material Providers
  • Figure 5: Global Endocrine Peptide Test Market, Major Resource Providers
  • Figure 6: Global Endocrine Peptide Test Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Endocrine Peptide Test Market, Major Distributors And Channel Partners
  • Figure 8: Global Endocrine Peptide Test Market, Key Technologies & Future Trends
  • Figure 9: Global Endocrine Peptide Test Market, Major Trends
  • Figure 10: Global Endocrine Peptide Test Market, Major End Users
  • Figure 11: Global Endocrine Peptide Test Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Endocrine Peptide Test Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Endocrine Peptide Test Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Endocrine Peptide Test Market - TAM, US$ Billion, 2025
  • Figure 15: Global Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Endocrine Peptide Test Market, Sub-Segmentation Of Dehydroepiandrosterone Sulphate, By Test-Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Endocrine Peptide Test Market, Sub-Segmentation Of Progesterone, By Test-Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Endocrine Peptide Test Market, Sub-Segmentation Of Luteinizing Hormone, By Test-Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Endocrine Peptide Test Market, Sub-Segmentation Of Thyroid Prolactin, By Test-Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Endocrine Peptide Test Market, Sub-Segmentation Of Oestradiol, By Test-Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Endocrine Peptide Test Market, Sub-Segmentation Of Human Chorionic Gonadotropin, By Test-Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Global Endocrine Peptide Test Market, Sub-Segmentation Of Thyroid-Stimulating Hormone, By Test-Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Global Endocrine Peptide Test Market, Sub-Segmentation Of Other Test-Types, By Test-Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Global Endocrine Peptide Test Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: Global Endocrine Peptide Test Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: Asia-Pacific, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: Asia-Pacific, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: Asia-Pacific, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: China, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: China, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: China, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: India, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: India, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: India, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Japan, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Japan, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Japan, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Australia, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Australia, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: Australia, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: Indonesia, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Indonesia, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Indonesia, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: South Korea, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: South Korea, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South Korea, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: Taiwan, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Taiwan, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Taiwan, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: South East Asia, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: South East Asia, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: South East Asia, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: Western Europe, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: Western Europe, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Western Europe, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: UK, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: UK, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: UK, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Germany, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Germany, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Germany, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: France, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: France, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: France, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Italy, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Italy, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Italy, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Spain, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Spain, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Spain, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Eastern Europe, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Eastern Europe, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: Eastern Europe, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: Russia, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: Russia, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: Russia, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: North America, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: North America, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: North America, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: USA, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: USA, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: USA, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: Canada, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: Canada, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Canada, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: South America, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: South America, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: South America, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Brazil, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Brazil, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Brazil, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Middle East, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Middle East, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Middle East, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 97: Africa, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 98: Africa, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 99: Africa, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 100: Global Endocrine Peptide Test Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 101: Global Endocrine Peptide Test Market - Company Scoring Matrix
  • Figure 102: Siemens AG Financial Performance
  • Figure 103: F. Hoffmann-La Roche AG Financial Performance
  • Figure 104: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 105: Merck KGaA Financial Performance
  • Figure 106: Becton Dickinson and Company Financial Performance
  • Figure 107: Global Endocrine Peptide Test Market, Competitive Benchmarking (In USD Billions)
  • Figure 108: Global Endocrine Peptide Test Market, Competitive Dashboard
  • Figure 109: Global Endocrine Peptide Test Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 110: Global, Endocrine Peptide Test Market Size Gain ($ Billion), Segmentation By Test-Type, 2025 – 2030
  • Figure 111: Global, Endocrine Peptide Test Market Size Gain ($ Billion), Segmentation By Technology, 2025 – 2030
  • Figure 112: Global, Endocrine Peptide Test Market Size Gain ($ Billion), Segmentation By End-User, 2025 – 2030

Frequently Asked Questions

The Endocrine Peptide Test market was valued at $9.95 billion in 2025, increased to $10.88 billion in 2026, and is projected to reach $14.88 billion by 2030.

The global Endocrine Peptide Test market is expected to grow at a CAGR of 8.1% from 2026 to 2035 to reach $14.88 billion by 2035.

Some Key Players in the Endocrine Peptide Test market Include, Siemens AG, F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Merck KGaA, Becton Dickinson and Company, Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics Incorp

Major trend in this market includes: Advancements in Immunoassay Testing Systems for Endocrine Peptide Testing. For further insights on this market. request a sample here

North America was the largest region in the endocrine peptide test market in 2025. The regions covered in the endocrine peptide test market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Midd

Customer representative image Book your 30 minutes free consultation with our research experts